InvestorsHub Logo
Followers 12
Posts 1150
Boards Moderated 0
Alias Born 10/17/2010

Re: winduken post# 6037

Tuesday, 03/20/2012 1:16:33 PM

Tuesday, March 20, 2012 1:16:33 PM

Post# of 7054
Great point wind. Here is some quote from dew's post and my comments,

Louis P. Scafuri, Chief Executive Officer of Syneron Medical, said, "Juvenis has developed a very unique dermal filler technology that provides advantages over the currently approved products and represents an attractive, multi-billion-dollar new commercial opportunity for Syneron.



wait a minute, multi billion dollar, applies to fibrocell as well, isn't it DEW?


We expect that Tenergel will be ideal for high-volume aesthetic applications and body contouring procedures given its tissue-like feel and its slow and natural degradation in the body. In addition, Tenergel is expected to have significant cost advantages over currently approved products and has strong intellectual property protection. We also believe that it can be an excellent product for wrinkles and lip augmentation procedures, further expanding its market opportunity."



Tissue like feel but not exactly tissue like fibrocell, of course it might be better than botox but inferior than Laviv.

Juvenis also claims slow and natural degradation, agree, better than botox but inferior than Laviv which has slowest and most natural degradation as it is patients own collagen.

Good luck with your BS dew!